GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

sipavibart   Click here for help

GtoPdb Ligand ID: 13905

Synonyms: AZD-3152 | AZD3152 | Kavigale®
Approved drug
sipavibart is an approved drug
Compound class: Antibody
Comment: Sipavibart (AZD3152) is an anti-SARS-CoV-2 monoclonal antibody that targets the virus' surface spike (S) protein [1,5]. This agent was designed as pre-exposure prophylaxis of COVID-19 in immunocompromised patients [4].
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CoV Spike glycoprotein SARS-CoV-2 Antibody Binding - - - 4
⤷ [4]